胰腺神经内分泌肿瘤的诊治进展  

New progress in research on diagnosis and treatment of pancreatic neuroendocrine tumors

作　　者：唐振勇[1] 唐耘天[1] TANG Zhen-yong;TANG Yun-tian(Department of Hepatobiliary Surgery,the People′s Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,China)

机构地区：[1]广西壮族自治区人民医院肝胆腺体外科,南宁530021

出　　处：《中国临床新医学》2018年第4期397-401,共5页CHINESE JOURNAL OF NEW CLINICAL MEDICINE

基　　金：广西科学研究与技术开发计划课题(编号:桂科攻12239015)

摘　　要：胰腺神经内分泌肿瘤(pancreatic neuroendocrine tumors,PNETs)是源于胰腺多能神经内分泌干细胞的一类肿瘤,故又称胰岛细胞瘤,临床少见或罕见,其发病率约为4~5/100万。该病经积极手术治疗后效果较好,但是由于PNETs自身类型多样,症状复杂多变,临床表现各异,在临床诊疗中极易造成误诊和漏诊。因此,早期正确的诊断是有效治疗PNETs的重要前提。该文针对目前胰腺神经内分泌肿瘤的诊治进展作一系统综述。Pancreatic tumors(PNETs)derived from pluripotent neuroendocrine pancreas stem cells are called islet cell tumor.PNETs are rare and unusual in clinical practice,whose incidence rate is about 4 to 5 ppm of the normal population.Surgery treatment has a good prognosis for the patients with PNETs.However,misdiagnosis and missed diagnosis of PNETs are likely to occur because of its type diversity and symptom complexity.Therefore,early and accurate diagnosis is very important for an effective treatment of PNETs.This paper is intended to systematically summarize the current progress in treatments of pancreatic neuroendocrine tumors.

关 键 词：胰腺神经内分泌肿瘤 诊断 治疗 

分 类 号：R657.5[医药卫生—外科学]